Immunostimulant, cerebroprotective & nootropic activities of andrographis paniculata leaves extract in normal & type 2 diabetic rats

Indian Journal of Medical Research

Volumn 135, Issue 5, 2012, Pages 636-641

  Radhika, P ^a   Annapurna, A ^a   Nageswara Rao, S ^a  

^a ANDHRA UNIVERSITY   (India)

Author keywords

Andrographis paniculata; Cerebroprotective; Diabetes; Immunostimulant; Nootropic; Rats; Streptozotocin

Indexed keywords

ANDROGRAPHIS PANICULATA LEAVES EXTRACT; IMMUNOSTIMULATING AGENT; MALONALDEHYDE; METHANOL; NOOTROPIC AGENT; PLANT EXTRACT; STREPTOZOCIN; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN FUNCTION; BRAIN INFARCTION SIZE; CAROTID ARTERY LIGATION; CONTROLLED STUDY; FEMALE; LYMPHOCYTE COUNT; MALE; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PERITONEUM MACROPHAGE; PLANT LEAF; QUANTITATIVE ANALYSIS; RAT; STREPTOZOCIN DIABETES;

ANDROGRAPHIS; ANIMALS; ANTIOXIDANTS; DIABETES MELLITUS, EXPERIMENTAL; IMMUNIZATION; LIPID PEROXIDATION; MALE; NIACINAMIDE; NOOTROPIC AGENTS; OXIDATIVE STRESS; PLANT EXTRACTS; PLANT LEAVES; RATS; STREPTOZOCIN;

EID: 84863192737     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Zargar AH, Sofi FA, Laway BA, Masoodi SR, Shah NA, Dar FA. Profile of neurological problems in diabetes mellitus retrospective analysis of data from 1294 patients. Ann Saudi Med 1997; 17: 20-5.
2. Musa BOP, Onyemelukwe GC, Hambolu JO, Bakari AG, Anumah FE. Cell-mediated immunity in type 2 diabetes mellitus patients in diabetic ketoacidosis, patients with controlled type 2 diabetes mellitus and healthy control subjects. J Med Med Sci 2010; 1: 290-5.
3. Whitmer RA. Type 2 diabetes and risk of cognitive impairment and dementia. Curr Neurol Neurosci Rep 2007; 7: 373-80.
4. Mishra SK, Sangwan NS, Sangwan RS. Andrographis paniculata (Kalmegh): A Review. Pharmacog Rev 2007; 1: 283-98.
5. Masiello P, Broca C, Gross R, Roye M, Manteghetti M, Hillaire-Buys D, et al. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 1998; 47: 224-9.
6. Tinn KI. Orbital venous anatomy of the rat. Lab Anim Sci 1979; 29: 636-8.
7. Trinder P. Determination of blood glucose using an oxidaseperoxidase system with a non-carcinogenic chromogen. J Clin Pathol 1969; 22: 158-61.
8. Morris R, Garrud P, Rawlins J, O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 1982; 297: 681-3.
9. Iwasaki Y, Ito T, Suzuki M, Nagahori T. Blood-brain barrier damage in reperfusion following ischaemia in the hippocampus of the Mongolian gerbil brain. J Neurol Sci 1989; 90: 155-65.
10. Jiang J, Wang W, Sun YJ. Neuroprotective effect of curcumin on focal cerebral ischaemic rats by preventing blood-brain barrier damage. Eur J Pharmacol 2007; 561: 54-62.
11. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-8.
12. Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys 1984; 21: 130-2.
13. Parsons MW, Barber PA, Desmond PM, Baird TA, Darby DG, Byrnes G, et al. Acute hyperglycaemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol 2002; 52: 20-8.
14. Davis L, Kuttan G. Immunomodulatory activity of Withania somnifera. J Ethnopharmacol 2000; 71: 193-200.
15. Makare N, Bodhankar S, Rangari V. Immunomodulatory activity of alcoholic extract of Mangifera indica L. in mice. J Ethnopharmacol 2001; 78: 133-7.
16. Puri A, Saxena R, Saxena RP, Saxena KC, Srivastava V, Tandon JS. Immunostimulant agents from Andrographis paniculata. J Nat Prod 1993; 56: 995-9.
17. Kumar RA, Sridevi K, Kumar NV, Nanduri S, Rajagopal S. Anticancer and immunostimulatory compounds from Andrographis paniculata. J Ethnopharmacol 2004; 92: 291-5.
18. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 2005; 64: 277-81.
19. Bruce DG, Harrington N, Davis WA, Davis TM. Dementia and its associations in type 2 diabetes mellitus: the Fremantle Diabetes Study. Diabetes Res Clin Pract 2001; 53: 165-72.
20. Curb JD, Rodriguez BL, Abbott RD, Petrovitch H, Ross GW, Masaki KH, et al. Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance. Neurology 1999; 52: 971-5.
21. Leibson CL, Rocca WA, Hanson VA, Cha R, Kokmen E, O'Brien PC, et al. The risk of dementia among persons with diabetes mellitus: a population-based cohort study. Ann N Y Acad Sci 1997; 826: 422-7.
22. Luchsinger JA, Tang MX, Stern Y, Shea S, Mayeux R. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 2001; 154: 635-41.
23. Macknight C, Rockwood K, Awalt E, McDowell I. Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dement Geriatr Cogn Disord 2002; 14: 77-83.
24. Griesmacher A, Kindhauser M, Andert SE, Schreiner W, Toma C, Knoebl P, et al. Enhanced serum levels of thiobarbituricacid- reactive substances in diabetes mellitus. Am J Med 1995; 98: 469-75.
25. Bémeur C, Ste-Marie L, Montgomery J. Increased oxidative stress during hyperglycaemic cerebral ischaemia. Neurochem Int 2007; 50: 890-904.
26. Chan SJ, Wong WS, Wong PT, Bian JS. Neuroprotective effects of andrographolide in a rat model of permanent cerebral ischaemia. Br J Pharmacol 2010; 161: 668-79.